Copy
NVTAG Nieuwsbrief
[Maart 2023]
In deze nieuwsbrief:
Van de Bestuurstafel | NVTAG Symposium: Where to go, if you don't know? Uncertainty in HTA decision making | In the Spotlight : Leiden University Medical Center | Market Access Workshop jong-NVTAG - summary | PhD theses / Proefschriften | 

Van de Bestuurstafel
Onzekerheid heeft een negatief imago. Maar, wat is een verhaal met een zekere afloop? Saai. Onzekerheid prikkelt onze fantasie. Hoe zou het kunnen gaan? Het daagt uit tot analyse. Wat kunnen we het beste doen op basis van wat we al wel weten? Vandaar dat NVTAG een symposium gaat houden over onzekerheid. Where to go if you don't know? Het antwoord op die vraag, in elk geval op 6 april, is: naar cursus- en vergadercentrum Domstad in Utrecht! Interessante sprekers, een mooie panel discussie en de uitreiking van de NVTAG prijs 2022, dat is zeker. Maar wie hem gaat winnen? Dat weet nu nog niemand…

NVTAG Symposium: Where to go, if you don't know? Uncertainty in HTA decision making

An important aspect of Health Technology Assessment is uncertainty, which complicates (reimbursement) decision making. During this symposium, speakers from different organizations will provide their views on how to deal with and communicate the uncertainty in recommendations and decisions.
Read further >>

In the Spotlight: Leiden University Medical Center

We thank our colleagues from MaastrichtHETA for the opportunity to light up this NVTAG newsletter and present our research group Outcomes versus Costs, part of the Medical Decision-Making unit at Leiden University Medical Center (LUMC).
 
Our research group started as a one-man army in 1996 and in 2008 forces were joined with a second health economist. The LUMC research group Outcomes versus Costs has had a strong tradition in cost-effectiveness analysis from the start and performs research in the areas of outcome measurement and more recently also value-based health care (VBHC). Our location within the hospital is ideal for close collaboration with many clinical LUMC departments. We perform applied analyses alongside clinical trials or use mathematical models to combine data from a variety of sources. We additionally conduct methodological research on topics like measurement and valuation of quality of life and wellbeing, measurement of health care costs and productivity losses due to illness, and analytical techniques like disease modelling and multiple imputation. Next to research, we also teach several courses in the curricula for medicine and biomedical sciences.
Read further >>

Market Access Workshop jong-NVTAG - summary

On the 1st of February, the Young-NVTAG board organized a Market Access workshop. Twenty-four participants travelled to Diemen to join the workshop held at Zorginstituut Nederland. The event started with Friso Coerts (Pfizer) giving a great insight into the pathway a new pharmacological drug has to go through to gain access to the market, and get reimbursed. While this process is well documented for pharmaceuticals, this is not necessarily the case for MedTech innovations. Wim Meijer (independent consultant) showed how this process is different for MedTech innovations and how to determine the value proposition of a new MedTech innovation. After an insight from the industry, Philip Klein from Zorginstituut Nederland showed how a government body performs their evaluation and how it comes to an advice to the minister of health.
Read further >>

PhD Theses / Proefschriften
Publiekssamenvatting proefschriften nu onlineTurnaround time - Proefschriften
Twitter
Website NVTAG
Email secretaris
Bereik ons op:
secretaris@nvtag.nl   |  jongnvtag@gmail.com

Geen mail meer van ons ontvangen? Mail ons!

Copyright © NVTAG, All rights reserved.






This email was sent to <<Email Address>>
why did I get this?    unsubscribe from this list    update subscription preferences
Nederlandse Vereniging voor Technology Assessment in de Gezondheidszorg · Albinusdreef 2 · Leiden 1011 AA · Nepal

Email Marketing Powered by Mailchimp